Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Theresa L. Arndt"'
Autor:
Timothy D. Henry, Katelyn Storey, Theresa L. Arndt, Christian W. Schmidt, Noel M. Bennett, Jay H. Traverse, Julia Wang, Ross Garberich
Publikováno v:
The American Journal of Cardiology. 129:1-4
Ranolazine is approved for patients with chronic stable angina but has not been formally studied in patients with refractory angina pectoris (RAP). Patients with RAP have limited therapeutic options and significant limitations in their quality of lif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55d97bfb908085c12568778416945b9d
https://doi.org/10.1016/j.amjcard.2020.05.020
https://doi.org/10.1016/j.amjcard.2020.05.020
Autor:
Anil K. Poulose, Katelyn Storey, Theresa L. Arndt, Patricia Mitchell, Jay H. Traverse, Ross F. Garberich, Timothy D. Henry, Stephanie Rutten-Ramos, Noel M. Bennett
Publikováno v:
Journal of the Minneapolis Heart Institute Foundation. 2:4-8
As the mortality of coronary artery disease improves and the population ages, an increasing number of patients with refractory angina are not candidates for percutaneous or surgical revascularization. We evaluated the impact of a dedicated refractory
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::75d5c8fa0c1eb28dccde8a263f003fd1
https://doi.org/10.21925/mplsheartjournal-d-18-00008
https://doi.org/10.21925/mplsheartjournal-d-18-00008
Autor:
Michael Tradewell, Theresa L. Arndt, Emmanouil S. Brilakis, Jay H. Traverse, Timothy D. Henry, Ross Garberich, Rahul Sharma, Anil Poulose, Louis P. Kohl
Publikováno v:
Catheterization and Cardiovascular Interventions. 92:1215-1219
BACKGROUND A significant proportion of patients with complex, advanced coronary artery disease have refractory angina (RA) despite maximal pharmacological therapy and are deemed suboptimal candidates for revascularization. These patients are frequent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::952ebcddfa64e0b8db148fefdeb807dc
https://doi.org/10.1002/ccd.27707
https://doi.org/10.1002/ccd.27707
Autor:
Vijay Iyer, Timothy D. Henry, Theresa L. Arndt, Jay H. Traverse, Randall K. Johnson, Annie Lips, Noel M. Bennett, Jill M. Morgan, Anil Poulose, Ross Garberich
Publikováno v:
Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine. 13:96-98
Patients with refractory angina (RA) have limited therapeutic options and significant limitations in their quality of life. Ranolazine is approved for patients with chronic stable angina but has not been studied in patients with RA. The Ranolazine Re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3ca01a3a77f19cadc3f7b4bf5fc0e03
https://doi.org/10.1097/hpc.0000000000000022
https://doi.org/10.1097/hpc.0000000000000022
Publikováno v:
Journal of the American College of Cardiology. 71:A1213
As the population ages, an increasing number of patients (pts) will develop refractory angina (RA) from severe myocardial ischemia not amenable for surgical or percutaneous revascularization (PCI). Despite significant limitations in their quality of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::38308f50976d97606c53766eb14e2170
https://doi.org/10.1016/s0735-1097(18)31754-6
https://doi.org/10.1016/s0735-1097(18)31754-6
Autor:
Stephanie Rutten-Ramos, Ross Garberich, Rachel E. Olson, Theresa L. Arndt, Anil Poulose, Vijay Iyer, Jay H. Traverse, Patricia Mitchell, Timothy D. Henry, Randall K. Johnson
Publikováno v:
Journal of the American College of Cardiology. 63(12)
As the population ages and coronary artery disease mortality declines, an increasing number of patients have advanced coronary artery disease. Many of these patients are suboptimal candidates for further revascularization and have refractory angina (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fc3c9c59df142b953e53fa74424dfa4
Autor:
Jill M. Morgan, Randall K. Johnson, Anil Poulose, Noel M. Bennett, Timothy D. Henry, Vijay Iyer, Jay H. Traverse, Theresa L. Arndt, Ross Garberich
Publikováno v:
Journal of the American College of Cardiology. 57(14)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e9db3885ff4f6af5751724e3f5efcb8
Autor:
Anil Poulose, Kayla M. Campbell, Charlene R. Boisjolie, Kim Juusola, Bradley A. Bart, Julia C. Espel, Andrey G. Zenovich, Timothy D. Henry, Daniel Satran, Alex R. Campbell, Theresa L. Arndt
Publikováno v:
American heart journal. 156(6)
Enhanced external counterpulsation (EECP) is a noninvasive treatment of patients with refractory angina. The immediate hemodynamic effects of EECP are similar to intra-aortic balloon pump counterpulsation, but EECP's effects on standard blood pressur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c1ed469c26c21a821f096104e558e71
https://pubmed.ncbi.nlm.nih.gov/19033023
https://pubmed.ncbi.nlm.nih.gov/19033023
Autor:
Vijay Iyer, Timothy D. Henry, Jay H. Traverse, Jill M. Morgan, Annie Lips, Rachel E. Olson, Theresa L. Arndt, Ross Garberich, Noel M. Bennett
Publikováno v:
Journal of the American College of Cardiology. 63:A1535
An increasing number of patients (pts) have refractory angina (RA) despite optimal medical management that is not amenable for revascularization. RA pts have a relatively low mortality rate (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::774e68f5a3f6e5b69952edaea0a689f1
https://doi.org/10.1016/s0735-1097(14)61538-2
https://doi.org/10.1016/s0735-1097(14)61538-2